Molecular and clinical evaluation of Turkish patients with lysinuric protein intolerance

被引:14
作者
Guzel-Ozanturk, Aysegul [1 ,2 ]
Ozgul, Riza Koksal [1 ,3 ]
Unal, Ozlem [1 ]
Hismi, Burcu [1 ]
Aydin, Halil Ibrahim [4 ]
Sivri, Serap [1 ]
Tokatli, Aysegul [1 ]
Coskun, Turgay [1 ]
Aksoz, Erol [2 ]
Dursun, Ali [1 ]
机构
[1] Hacettepe Univ, Fac Med, Inst Child Hlth, Dept Pediat,Metab Unit, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Dept Mol Biol, Ankara, Turkey
[3] Hacettepe Univ, Inst Child Hlth, Ankara, Turkey
[4] Gulhane MMF, Dept Pediat, Div Metab Disorders, Ankara, Turkey
关键词
Lysinuric protein intolerance; SLC7A7; y(+)LAT-1; Cationic amino acids; Hyperammonemia; SLC7A7; Y(+)LAT-1; GENE; DISEASE;
D O I
10.1016/j.gene.2013.03.033
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lysinuric protein intolerance is an autosomal recessive metabolic disorder caused by defective transport of the cationic amino acids lysine, arginine and ornithine in the epithelial cells of the basolateral membrane in the small intestine and renal tubules. Mutations in the solute carrier family 7, member 7, SLC7A7, gene cause this multisystemic disease with a variety of clinical symptoms such as hepatosplenomegaly, osteoporosis, hypotonia, developmental delay, pulmonary insufficiency or end-stage renal disease. In the present study, genomic structure of SLC7A7 in six Turkish patients with lysinuric protein intolerance was examined in order to detect disease causing mutations by denaturing high pressure liquid chromatography and direct sequencing. Four novel mutations were identified in SLC7A7: c.223insGTC, p.Val74_Ile75insVal; c.283insTGG, p.Glu94_Thr95insTrp; c.344_347deITTGC, p.Leu115LeufsX53; and c.1099insT, p.Ile367TyrfsX16. Clinical and biochemical findings were evaluated together with these molecular analyses. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 295
页数:3
相关论文
共 16 条
[1]  
[Anonymous], 2001, METABOLIC MOL BASES
[2]  
BEHBEHANI AW, 1983, MONATSSCHR KINDERH, V131, P784
[3]   SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance [J].
Borsani, G ;
Bassi, MT ;
Sperandeo, MP ;
De Grandi, A ;
Buoninconti, A ;
Riboni, M ;
Manzoni, M ;
Incerti, B ;
Pepe, A ;
Andria, G ;
Ballabio, A ;
Sebastio, G .
NATURE GENETICS, 1999, 21 (03) :297-301
[4]   Lysinuric protein intolerance (LPI): A multi organ disease by far more complex than a classic urea cycle disorder [J].
de Baulny, Helene Ogier ;
Schiff, Manuel ;
Dionisi-Vici, Carlo .
MOLECULAR GENETICS AND METABOLISM, 2012, 106 (01) :12-17
[5]   Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat [J].
Font-Llitjos, Mariona ;
Rodriguez-Santiago, Benjamin ;
Espino, Meritxell ;
Sillue, Ruth ;
Manas, Sandra ;
Gomez, Laia ;
Perez-Jurado, Luis A. ;
Palacin, Manuel ;
Nunes, Virginia .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (01) :71-79
[6]   Functional analysis of novel mutations in y+LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI) [J].
Mykkänen, J ;
Torrents, D ;
Pineda, M ;
Camps, M ;
Yoldi, ME ;
Horelli-Kuitunen, N ;
Huoponen, K ;
Heinonen, M ;
Oksanen, J ;
Simell, O ;
Savontaus, ML ;
Zorzano, A ;
Palacín, M ;
Aula, P .
HUMAN MOLECULAR GENETICS, 2000, 9 (03) :431-438
[7]   The Finnish Disease Heritage III: the individual diseases [J].
Norio, R .
HUMAN GENETICS, 2003, 112 (5-6) :470-526
[8]   The molecular bases of cystinuria and lysinuric protein intolerance [J].
Palacín, M ;
Borsani, G ;
Sebastio, G .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (03) :328-335
[9]  
Sebastio G, 2006, GENEREVIEWS
[10]   Lysinuric Protein Intolerance: Reviewing Concepts on a Multisystem Disease [J].
Sebastio, Gianfranco ;
Sperandeo, Maria P. ;
Andria, Generoso .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2011, 157C (01) :54-62